Primary Site >> Colorectal Cancer

Gene >> ELK1

Journal: Mol Cancer. 2010 Feb 19;9:39.
Title: Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.
Author: Tabu, Kouichi|Kimura, Taichi|Sasai, Ken|Wang, Lei|Bizen, Norihisa|Nishihara, Hiroshi|Taga, Tetsuya|Tanaka, Shinya
PMID: 20167130
Journal: PLoS One. 2013 Jun 20;8(6):e66255.
Title: hypoxia-inducible factors activate CD133 promoter through ETS family transcription factors.
Author: Ohnishi, Shunsuke|Maehara, Osamu|Nakagawa, Koji|Kameya, Ayano|Otaki, Kanako|Fujita, Hirotoshi|Higashi, Ryosuke|Takagi, Kikuko|Asaka, Masahiro|Sakamoto, Naoya|Kobayashi, Masanobu|Takeda, Hiroshi
PMID: 23840432
Journal: Mol Cancer Res. 2016 Mar;14(3):267-77.
Title: Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1.
Author: Kent, Oliver A|Mendell, Joshua T|Rottapel, Robert
PMID: 26747707
Journal: Genome Res. 2016 Apr;26(4):541-53.
Title: A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1.
Author: Hollander, Dror|Donyo, Maya|Atias, Nir|Mekahel, Keren|Melamed, Zeev|Yannai, Sivan|Lev-Maor, Galit|Shilo, Asaf|Schwartz, Schraga|Barshack, Iris|Sharan, Roded|Ast, Gil
PMID: 26860615